Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16
Clinical Trial Data: SURMOUNT and SURPASS Programs Tirzepatide was studied in two major trial programs: SURPASS (diabetes) and SURMOUNT (obesity)
They mimicked a gut hormone, GLP-1, that modulates insulin, glucagon, and gastric emptying
Resistance training integrated as a core component of GLP-1 protocols
But dont take my word for it
PLoS One 7 (8), e42529
While seven in ten (69%) recognised the importance of a balanced diet during GLP-1 treatment, fewer than half of respondents identified protein (46%) or fibre (48%) as essential, despite their critical role in preserving lean muscle mass and supporting long-term metabolic and digestive health
US$ 24.35
US$ 26.25
US$ 25.48
US$ 25.51
US$ 23.41
US$ 25.41
